IMR Press / FBL / Volume 13 / Issue 9 / DOI: 10.2741/2927

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Chemokines in lupus nephritis
Show Less
1 Departments of Nephrology and Rheumatology, Medizinische Poliklinik, Klinikum der Universitat Munchen-Innenstadt, Munich, Germany

*Author to whom correspondence should be addressed.

 

Front. Biosci. (Landmark Ed) 2008, 13(9), 3312–3320; https://doi.org/10.2741/2927
Published: 1 May 2008
Abstract

Lupus nephritis is a common solid organ manifestation of systemic lupus erythematosus (SLE). The disease is tightly linked to the production of autoantibodies and circulating immune complexes, i.e. immune complex glomerulonephritis. In this process chemokines mediate multiple biological effects, e.g. orchestrating proinflammatory microenvironments, the recruitment of immune cell subsets into the kidney, as well as the local activation of such immune effector cells. Autoimmune mice with targeted deletions of certain single chemokines or chemokine receptors are protected from renal autoimmune tissue injury. Interventional studies with specific antagonists against certain chemokines and chemokine receptors further support these findings. In this review we summarise the available experimental and human data on the expression and functional role of chemokines and chemokine receptors in lupus nephritis.

Share
Back to top